Breathing Easier, Healing Deeper: How Halo Salt Therapy Supports Chronic Respiratory and Skin Conditions

Halo salt therapy can be framed as a well-tolerated, evidence-supported adjunct for chronic
respiratory, ENT, and skin conditions, especially when families are looking for drugfree ways to
support healing while you work on root causes.

Families often ask a version of the same question: “Is there anything else we can do to accelerate healing, something that works with the body instead of against it?” For many, this comes after months or years of medications that manage symptoms but never fully resolve the underlying pattern of inflammation, infection, or immune dysregulation.

In those situations, the answer is often yes. Some of the most powerful tools are not new inventions but refined versions of very old therapies, and salt is one of them. Salt-based therapies have been used for centuries in Eastern Europe, where people with chronic lung and skin diseases sought out natural salt caves and mines for symptom relief. Modern halotherapy is a structured, technology-supported evolution of those spa and climatotherapy traditions.

At Fundamental Healing, we’ve incorporated a Halo Salt Therapy Chamber as a complementary support for patients working through chronic respiratory issues, persistent skin conditions, and long-haul recovery from COVID-19 and other viral illnesses. We use it as one piece of a comprehensive plan that also includes functional medicine evaluation, environmental detoxification, nutrition, and nervous system support. Here’s what halotherapy is, how it works, and why it may be worth adding to your healing roadmap.

What Is Halo Salt Therapy?

Halotherapy — from the Greek halos, meaning salt — is a dry salt therapy rooted in European speleotherapy, where patients historically spent time in natural salt caves to improve chronic bronchitis, asthma, and dermatitis.

In a modern halo chamber, those environmental conditions are recreated in a controlled, reproducible way. Inside the chamber, a medical device called a halogenerator grinds pharmaceutical-grade sodium chloride into microscopic particles, typically 1–5 microns, and disperses them into the air as a dry aerosol. The particle size is small enough to reach the lower respiratory tract, including bronchioles and, to some extent, terminal bronchi, where chronic inflammation and mucus stasis often reside. You simply sit, breathe normally, and let the salt particles contact your airways and skin while you rest, read, or play.

This is not table salt. Pharmaceutical-grade sodium chloride is highly purified, free of iodine, anti-caking agents, or contaminants, and carefully controlled for particle size and concentration for safe inhalation. The goal is a consistent, low-dose exposure that leverages salt’s physical and biochemical properties without overloading the airways.

The Science: Five Key Mechanisms

1. Supporting Mucociliary Clearance

Salt is hygroscopic, meaning it draws and holds water molecules. When dry salt particles travel into the nasal passages, bronchi, and smaller airways, they attract moisture to the airway surface layer, indirectly thinning thick mucus and making it less viscous. This hydration shift helps the tiny cilia — the hair-like structures lining the respiratory epithelium — beat more effectively and move mucus, allergens, and debris up and out of the lungs and sinuses.

For anyone dealing with chronic congestion, recurrent bronchitis, or the “lung fatigue” that lingers after viral infections, improved mucociliary clearance is not just a comfort measure; it is a core defense mechanism that reduces the time pathogens and irritants remain in contact with the mucosa. A narrative review of halotherapy for chronic respiratory disorders noted improvements in mucociliary elimination and lung function, along with better health-related quality of life in conditions such as asthma and COPD, when halotherapy was used as an adjunct.

A clinical series from the National Institute of Rehabilitation in Romania found that patients with bronchial asthma, chronic bronchitis, and chronic obstructive bronchopneumopathy (COPD) who received halotherapy in an artificial salt-mine environment showed activation of anti-inflammatory mechanisms and a reduction in markers of chronic airway inflammation over the course of treatment. This is consistent with the idea that when mucus moves, inflammation can resolve more effectively.

2. Antimicrobial and Biofilm-Disrupting Action

Salt also exerts an osmotic effect. A hypertonic environment draws water out of microbial cells and can inhibit the growth and viability of certain bacteria and fungi. In vitro and clinical observations suggest that dry salt aerosol helps create conditions that are less hospitable to pathogens, including some that participate in biofilm formation in the upper and lower airway.

While research is still developing, reviews on halotherapy describe its adjuvant use in chronic respiratory diseases, including cystic fibrosis, COPD, and chronic bronchitis, where stubborn mucus and biofilms contribute to recurrent infection. Importantly, halotherapy is not a substitute for antibiotics or antiviral therapy when those are clearly indicated, but it can be a supportive layer that reduces the microbial load the immune system is fighting, supports clearance of secretions where organisms hide and replicate, and does so without contributing to antibiotic resistance or drug-induced dysbiosis.

For patients who have cycled through multiple antibiotic courses, this drug-free antimicrobial support can be particularly valuable as you work to rebuild the microbiome and immune balance.

3. Anti-Inflammatory and Immunomodulating Effects

Beyond mechanical and osmotic effects, inhaled salt appears to modulate immune activity in the airways and systemically. Clinical work in salt chambers has documented shifts in neutrophil phagocytosis, oxidative burst capacity, and markers of non-specific anti-infectious resistance. In the Sandu et al. study, patients with asthma, chronic bronchitis, and COPD undergoing halotherapy showed evidence of decreased inflammatory activity and reduced allergic sensitization.

Broader reviews of halotherapy report improvements in forced expiratory volume (FEV1), symptom scores, and quality-of-life measures across different chronic respiratory populations when halotherapy is added to standard care, though study designs and protocols vary. A review on halotherapy for chronic respiratory disorders emphasizes that, while no formal guidelines yet exist, the available evidence supports its role as a possible adjuvant therapy and calls for more structured randomized trials.

In the context of long COVID and other post-viral syndromes, persistent symptoms often correlate with ongoing low-grade inflammation, oxidative stress, and impaired mucosal barrier function. Early clinical opinions and case discussions have proposed halotherapy as a supportive tool in rehabilitation of COVID-related respiratory disease, especially when combined with respiratory physiotherapy and graded exercise. Although high-quality long-COVID-specific trials are still limited, the mechanisms of improved mucus clearance, reduced airway inflammation, and possible immune modulation are directly relevant.

4. Skin Barrier and Microbiome Support

Halotherapy does not stop at the lungs. The same fine salt particles that reach the airways also settle on exposed skin, where they can support barrier repair and microbiome balance. Historically, saltwater and mineral baths have been used to treat eczema, psoriasis, and chronic dermatitis; dry salt therapy aims to deliver similar benefits without the need for immersion.

A review on halotherapy for skin diseases reports that salt exposure appears to normalize skin pH, support keratinocyte function, and promote ceramide-mediated barrier repair, which are core needs in atopic dermatitis and other chronic dermatoses. Clinically, patients often report reductions in itch, exudation, and erythema, along with a longer remission period after a course of sessions. The same review notes that halotherapy can be considered an additional therapy in conditions such as psoriasis and atopic dermatitis, rather than a replacement for all other treatments.

Mechanistically, salt’s mild desiccating and antimicrobial effects help reduce overgrowth of pathogenic organisms on the skin surface, while its influence on microcirculation and epidermal turnover can support repair of damaged or inflamed tissue. For children and adults who are steroid-sensitive or seeking to minimize long-term topical steroid exposure, this kind of non-pharmacologic support can be an important part of a broader plan that also includes nutrition, gut health, and environmental triggers.

5. Chronic ENT Conditions: Ears, Nose, and Throat

If your child has been through round after round of antibiotics for ear infections, or you have lived with chronic sinusitis that never fully clears, this is where the research gets particularly compelling. The same mechanisms that make halotherapy helpful for lower airway disease — thinning mucus, supporting mucociliary clearance, and modulating inflammation — apply to the upper airways: sinuses, nasal passages, adenoids, tonsils, and middle ear.

A double-blind, placebo-controlled randomized clinical trial by Gelardi et al. evaluated an aerosolized halotherapy product (Aerosal) in children with sub-obstructive adenotonsillar hypertrophy. Forty-five children, aged 4 to 12, were randomized to active treatment or placebo, with the primary outcome being at least a 25% reduction in adenoid and/or tonsil size. After ten sessions, the halotherapy group showed a significantly greater reduction in adenoid and tonsillar hypertrophy compared with placebo, statistically significant improvements in tympanometric values reflecting better middle ear ventilation and pressure regulation, and a meaningful reduction in hearing loss associated with effusion or obstruction.

Importantly, no serious adverse effects were reported, and the children tolerated the sessions well, often perceiving them as play time rather than a medical procedure. The authors concluded that Aerosal halotherapy could be considered a viable adjunct, though not a replacement, to conventional treatment in adenotonsillar disease.

This is clinically meaningful because enlarged adenoids and tonsils are common drivers of chronic ear infections, sleep-disordered breathing, and recurring upper respiratory infections in children. Families are often presented with a binary choice: more steroids or surgery. Halotherapy offers a documented, non-invasive, drug-free adjunct to try while you also address diet, allergens, oral posture, and other contributors.

For chronic sinusitis and rhinitis, a number of clinical observations and smaller trials summarized in halotherapy reviews report improvements in nasal obstruction, discharge, and mucosal edema, as well as the ability to manage acute purulent maxillary sinusitis without puncture when dry salt inhalation is added. Mechanistically, salt particles help decrease mucosal swelling that blocks sinus drainage, thin viscous mucus that traps bacteria, and create a local environment less favorable to microbial overgrowth.

For adults with chronic pharyngitis, rhinitis, and recurrent throat infections, the same antimicrobial and anti-inflammatory mechanisms apply. When you see a pattern of “antibiotic, brief relief, then relapse,” it often reflects an inflamed, compromised mucosal barrier rather than simply “bad luck.” Halotherapy is designed to work at that barrier level while other root-cause work proceeds.

Who May Benefit Most

In our practice, Halo Salt Therapy is most often considered for patients dealing with:

• Chronic respiratory infections – recurrent sinusitis, bronchitis, lingering post-viral cough, or “every cold goes to the chest.”
• Long COVID / post-COVID recovery – especially reduced lung capacity, exertional dyspnea, residual cough, and ongoing airway inflammation.
• Asthma and allergic rhinitis – as an adjunct to controller medications, allergen avoidance, and anti-inflammatory nutrition, with some studies suggesting improved symptom control and lung function.
• Chronic skin conditions – eczema, psoriasis, atopic dermatitis, and chronic dermatitis where barrier repair and microbiome balance are ongoing challenges.
• COPD or diminished lung function from environmental exposure or toxin burden – where gentle, non-pharmacologic support for mucociliary clearance and quality of life is desired.
• Chronic ENT conditions – enlarged adenoids or tonsils, recurring otitis media, chronic sinusitis, rhinitis, or pharyngitis in both children and adults.

Halotherapy is generally well tolerated, but it is not appropriate for everyone. Caution is typically advised in patients with uncontrolled severe asthma, active hemoptysis, certain cardiac conditions, or acute infections with high fever, and it should always be integrated thoughtfully with a patient’s existing care plan. This is why we screen carefully and tailor recommendations rather than treating it as a one-size-fits-all wellness service.

How We Use Halo Salt Therapy at Fundamental Healing

Halo Salt Therapy is not positioned as a standalone cure at Fundamental Healing. Instead, we view it as one layer in a comprehensive, personalized healing roadmap. In practical terms, that means we weave sessions into a broader plan that may also include:

• Functional medicine workups to identify drivers such as nutrient deficiencies, mitochondrial dysfunction, chronic infections, mold or environmental toxins, and immune dysregulation.
• Environmental detox and remediation strategies, particularly in patients with mold exposure, poor indoor air quality, or high particulate burden.
• Nutrition, microbiome, and lifestyle protocols to lower systemic inflammation and support tissue repair.
• Nervous system and sleep support, which profoundly influence respiratory and skin healing.

Patients typically commit to a series of sessions — for example, 8–15 sessions over several weeks — because the research and clinical experience suggest that benefits accumulate with repeated exposures rather than a single visit. We monitor responses, adjust frequency, and coordinate with existing medical providers when needed.

If you’ve been told your lungs are “fine” but you know they are not, or if your skin has been treated but never truly healed, it may be time to look deeper. Sometimes, healing begins with something as simple and elemental as breath, layered thoughtfully into a root-cause plan that honors the complexity of your body.

If you’re curious whether Halo Salt Therapy could be an appropriate adjunct for you or your child, reach out to our team to explore whether it aligns with your diagnosis, current treatment plan, and overall healing goals.

References

Gelardi, M., Cassano, M., Fiorella, M. L., Fiorella, R., & Russo, C. (2013). Double-blind placebo-controlled randomized clinical trial on the efficacy of Aerosal® halotherapy in the treatment of sub-obstructive adenotonsillar hypertrophy and related diseases. International Journal of Pediatric Otorhinolaryngology, 77(11), 1818–1824. https://pubmed.ncbi.nlm.nih.gov/24041858/

Horvath, T. (2022). Halotherapy for chronic respiratory disorders. Alternative Therapies in Health and Medicine, 28(2), 50–58. https://pubmed.ncbi.nlm.nih.gov/32827399/

Li, X. et al. (2025). “Halotherapy improves the prognosis of acute respiratory distress syndrome and alleviates pyroptosis-related biomarkers.” Discover Medicine, Springer Nature.

Reilly, J. et al. (2020). “The Importance of Halotherapy in the Treatment of COVID-19 Related Diseases.” Journal of Clinical and Experimental Investigations, 11(4).

Sandu, I., Tamaş, I., Mogoantă, L., et al. (2014). Surveys on therapeutic effects of halotherapy chamber with artificial salt-mine environment on patients with certain chronic allergenic respiratory pathologies. Journal of Medicine and Life. https://pmc.ncbi.nlm.nih.gov/articles/PMC4391365/

Systematic Review (2022). Halotherapy and chronic respiratory disease outcomes — 13-study analysis. Referenced in Salt Chamber Inc. Research Compendium and PubMed.

Vladeva, E. (2023). Halotherapy in the treatment of skin diseases. MEDIS – Medical Science and Research. https://ouci.dntb.gov.ua/en/works/9ZJRmqO9/ Vladeva, E. (2018). Halotherapy – benefits and risks. Scripta Scientifica Salutis Publicae, 4(1), 7–12. https://journals.mu-varna.bg/index.php/sssp/article/view/5010